科睿唯安(Clarivate Analytics,原汤森路透)2019年5月9日发布的ESI最新数据显示(数据覆盖时间范围为2009年1月1日-2019年2月28日),本期全球共有5864个机构登上ESI榜单,我校位于第2095位。我校临床医学学科在该学科上榜的全球4161个机构中,排名第1251位,继续位居该学科ESI全球前3‰。
一、我校ESI学科建设概况
1.我校ESI学科基本情况
表1 我校ESI总体排名情况
机构名称 | 总机构数 | 排名 | 百分比排名 | WoS论文数 | 被引频次 | 篇均被引频次 | 高水平论文 | 高被引论文 |
福建医科大学 | 5864 | 2095 | 35.73% | 5744 | 41736 | 7.27 | 15 | 15 |
注:我校本期WoS论文较上期(2019年3月更新)增长113篇 | ||||||||
表2 我校ESI全球前1%学科排名情况
学科 | 总机构数 | 排名 | 百分比排名 | WoS论文数 | 被引频次 | 篇均被引频次 | 高水平论文 | 高被引论文 |
临床医学 | 4161 | 1251 | 30.06% | 3031 | 19732 | 6.51 | 8 | 8 |
注:我校本期临床医学学科排名情况与上期(2019年3月更新)相比,百分比排名上升0.14%;WoS论文增长69篇 | ||||||||
2.我校ESI潜力学科基本情况
目前,我校18个ESI潜力学科中,潜力值位于前三的学科分别是:化学(本期0.650,上期0.659)、药理学与毒理学(本期0.631,上期0.623)、神经科学与行为学(本期0.579,上期0.537),各学科潜力值如下图1所示:

图1 我校ESI学科潜力值基本情况
二、我校高水平论文基本情况
本期我校共有15篇高水平论文,其中高被引论文15篇(10篇文章涉及研究前沿)。高水平论文学科分布情况为:临床医学8篇、材料科学1篇、分子生物学和遗传学1篇、神经科学与行为学1篇、化学1篇、物理学1篇、药理学与毒理学1篇、精神病学与心理学1篇。高水平论文基本情况如下表3所示:
表3 我校高水平论文概览
序号 | 我校作者 | 文章题名 | 学科 | 被引次数 | 出处 |
1 | Li, Li;Li, Haifu; Sheng, Xinan; Cui, Chuanliang; Chi, Zhihong; Li, Siming; Han, Mei; Mao, Lili; Lin, Xuede | Phase Ii, Open-label, Single-arm Trial Of Imatinib Mesylate In Patients With Metastatic Melanoma Harboring C-kit Mutation Or Amplification | 临床医学 | 291 | J CLIN ONCOL,2011, 29 (21): 2904-2909 |
2 | Lin, Xiaoyan | Randomized, Double-blind, Placebo-controlled Phase Iii Trial Of Apatinib In Patients With Chemotherapy-refractory Advanced Or Metastatic Adenocarcinoma Of The Stomach Or Gastroesophageal Junction | 临床医学 | 213 | J CLIN ONCOL,2016, 34 (13): 1448-+ |
3 | Bruijn, S. M.; Meijer, O. G. | Assessing The Stability Of Human Locomotion: A Review Of Current Measures | 临床医学 | 138 | J R SOC INTERFACE 2013,10 (83) |
4 | Zhang, Da; Wu, Ming ; Zeng, Yongyi; Wu, Lingjie; Wang, Qingtang; Liu, Xiaolong; Liu, Jingfeng | Chlorin E6 Conjugated Poly(dopamine) Nanospheres As Pdt/ptt Dual-modal Therapeutic Agents For Enhanced Cancer Therapy | 材料科学 | 119 | ACS APPL MATER INTERFACES, 2015,7 (15): 8176-8187 |
5 | Huang,Changming; Zheng, Chaohui; Li, Ping | Morbidity And Mortality Of Laparoscopic Versus Open D2 Distal Gastrectomy For Advanced Gastric Cancer: A Randomized Controlled Trial | 临床医学 | 101 | J CLIN ONCOL,2016, 34 (12): 1350-+ |
6 | Ren, Meixia | Genome-wide Association Analysis Identifies Novel Blood Pressure Loci And Offers Biological Insights Into Cardiovascular Risk | 分子生物学与遗传学 | 83 | NAT GENET,2017, 49 (3): 403-415 |
7 | Chen, Chun | Gefitinib Versus Vinorelbine Plus Cisplatin As Adjuvant Treatment For Stage Ii-iiia (n1-n2) Egfr-mutant Nsclc (adjuvant/ctong1104): A Randomised, Open-label, Phase 3 Study | 临床医学 | 51 | LANCET ONCOL,2018, 19 (1): 139-148 |
8 | Wu, Xilin; Chen, Xiaochun | Trem2 Is A Receptor For Beta-amyloid That Mediates Microglial Function | 神经科学与行为学 | 29 | NEURON, 2018,97 (5): 1023-+ |
9 | Zeng, Yongyi | Double Photosystems-based Z-scheme Photoelectrochemical Sensing Mode For Ultrasensitive Detection Of Disease Biomarker Accompanying Three-dimensional Dna Walker | 化学 | 27 | ANAL CHEM,2018, 90 (11): 7086-7093 |
10 | Fu, Jing | Precision Diagnosis And Treatment Of Liver Cancer In China | 临床医学 | 17 | CANCER LETT,2018, 412: 283-288 |
11 | Zhou, Yan | Changing Cancer Survival In China During 2003-15: A Pooled Analysis Of 17 Population-based Cancer Registries | 临床医学 | 16 | LANCET GLOB HEALTH, 2018, 6 (5): E555-E567 |
12 | Pan, Jian Ji | International Guideline For The Delineation Of The Clinical Target Volumes (ctv) For Nasopharyngeal Carcinoma | 临床医学 | 15 | RADIOTHER ONCOL,2018, 126 (1): 25-36 |
13 | Zhang, Da; Wu, Ming; Cai, Zhixiong; Liao, Naishun; Ke, Kun; Liu, Hongzhi; Li, Ming; Liu, Xiaolong; Liu, Jingfeng | Chemotherapeutic Drug Based Metal-organic Particles For Microvesicle-mediated Deep Penetration And Programmable Ph/nir/hypoxia Activated Cancer Photochemotherapy | 物理学 | 13 | ADVANCED SCI,2018, 5 (2) |
14 | Huang, Jiaming | Epidemiology Of Carbapenem-resistant Enterobacteriaceae Infections: Report From The China Cre Network | 药理学与毒理学 | 11 | ANTIMICROB AGENTS CHEMOTHER,2018, 62 (2) |
15 | Jiang, Rifeng | Associations Of Depression, Anxiety And Ptsd With Neurological Disability And Cognitive Impairment In Survivors Of Moyamoya Disease | 精神病学与心理学 | 4 | PSYCHOL HEALTH MED,2019, 24 (1): 43-50 |
注:此表作者仅体现署名单位中包含“福建医科大学”的作者。 | |||||
| |||||



